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Plant hormones: Brassinosteroids in the spotlight
Steven D. Clouse
Recent studies on dwarf mutants of the model plant
Arabidopsis thaliana have provided convincing
evidence that brassinosteroids — natural plant products
similar to animal steroid hormones — are essential for
normal plant growth and development.
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Brassinosteroids are plant natural products with structural
similarities to animal steroid hormones. They are found
throughout the plant kingdom, and when applied exoge-
nously at nanomolar to micromolar levels in a number of
test systems, they exhibit a wide spectrum of physiological
effects, including a marked promotion of cell elongation
[1]. Like animal steroid hormones, brassinosteroids regu-
late the expression of specific genes [2,3]. Together, these
facts suggest that brassinosteroids may serve as one of the
critical signals controlling plant growth and development. 
Those few laboratories that have consistently worked on
brassinosteroids over the past decade have proposed that
these compounds deserve recognition as a sixth class of
plant hormones, equal in stature to the better known
auxins, cytokinins, gibberellins, abscisic acid and ethylene
[4]. However, the plant community at large has been very
slow to recognize brassinosteroids as important growth
regulators. This may have been because of a lack of
unequivocal proof that brassinosteroids are essential for
plant growth and development, despite the large body of
physiological data gathered since the first publication of a
brassinosteroid structure [5]. Furthermore, the molecular
mechanism of brassinosteroid action is uncertain, although
one might argue from structural considerations that they
are likely to work by a mechanism similar to that of animal
steroid hormones, which generally act via a soluble recep-
tor–ligand complex that binds to nuclear sites to regulate
the expression of specific genes [6].
Mutants of Arabidopsis thaliana that are deficient in or
insensitive to plant hormones have been used extensively
in the study of abscisic acid, auxin, ethylene and gib-
berellin action over the past decade [7]. Hormone-
deficient mutants usually result from lesions in genes
encoding biosynthetic enzymes and are rescued to a wild-
type phenotype by treatment with the hormone. This is
generally considered to be strong evidence that the
hormone in question is required for a normal phenotype.
Hormone-insensitive mutants may show the same pheno-
type as deficient mutants, but are not rescued by hormone
treatment. Insensitive mutants usually result from lesions
in genes encoding the hormone receptor or elements of
the signal transduction pathway. 
Numerous structure–function analyses have defined the
specific requirements for brassinosteroid activity [1]. In
order to transform a commonly occurring plant sterol such
as campesterol into an active brassinosteroid, the cell must
accomplish a series of reductions, oxidations and epimer-
izations. The complete biosynthetic pathway of the brassi-
nosteroid brassinolide, via campesterol, has recently been
defined by several groups in Japan [8]. With the brassinos-
teroid biosynthetic pathway now established (Fig. 1), it
should be possible to identify mutants that affect rate-
controlling steps in the pathway, resulting in reduced
brassinosteroid levels in the mutant plants. The pheno-
type of such mutants would provide a critical test of the
importance of brassinosteroids in normal plant growth and
development. For example, if brassinosteroids are
required for cell elongation, brassinosteroid-deficient
mutants would be expected to display a dwarf phenotype.
A direct search for brassinosteroid biosynthetic mutants
has not been undertaken, but the re-examination of
Arabidopsis dwarf mutants, selected by mutant screens for
defects in physiological processes thought to be indepen-
dent of brassinosteroids, has uncovered a series of very
exciting results.
When dicotyledonous plants, such as Arabidopsis, are
grown in darkness they show an etiolated phenotype
which includes an elongated hypocotyl, a pronounced
apical hook, small folded cotyledons, undeveloped chloro-
plasts and repression of light-regulated gene expression.
When such plants are grown in the light, hypocotyl elon-
gation is inhibited, cotyledons open, primary leaves and
mature chloroplasts develop and transcript levels of light-
regulated genes increase dramatically. To study how light
controls developmental pathways, a number of Arabidopsis
mutants — known as det (de-etiolated) and cop (constitu-
tive photomorphogenesis) mutants — have been identi-
fied that have characteristics of light-grown plants even
when grown in complete darkness [9]. Loss-of-function
mutations in the DET and COP genes lead to pleiotropic
defects in development in both the dark and the light.
One such mutant, det2, when grown in the light has an
extremely dwarfed phenotype (as a result of reduced cell
size), dark green leaves, reduced male fertility and apical
dominance, delayed flowering and a delay of leaf and
chloroplast senescence. Such a broad spectrum of effects
shows that DET2 plays an important role in development
throughout the Arabidopsis life cycle.
The DET2 gene has recently been cloned by chromo-
some walking, and sequence analysis revealed a surpris-
ing similarity to mammalian steroid 5a-reductases, which
catalyze the NADPH-dependent conversion of testos-
terone to dihydrotestosterone [10]. There is 38–42 %
sequence identity between DET2 and the mammalian
genes, and the sequence similarity increases to 54–60 %
when conservative substitutions are taken into account.
Even more convincing, 80 % of the conserved residues in
the mammalian enzymes are found in the DET2 protein,
including a glutamate that is absolutely required for
mammalian enzyme activity. This glutamate is changed
to a lysine in the det2-1 and det2-6 alleles, both of which
have very severe effects in spite of being simple missense
mutations. The first step in the brassinosteroid biosyn-
thetic pathway is the reduction of campesterol to campes-
tanol, which is strikingly similar to the conversion of
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The proposed biosynthetic pathway to brassinolide from campesterol.
Recent results suggest that normal plant development requires
brassinosteroid activity, which alters gene expression and leads to cell
elongation. The TCH4 gene encodes a brassinosteroid-regulated
xyloglucan endotransglycosylase that may act on cell walls during
brassinosteroid-promoted growth [2,3]. If brassinosteroid levels are
reduced by mutations in genes (DET2 or CPD) encoding
brassinosteroid biosynthetic enzymes, a dwarf phenotype results. A
similar dwarf phenotype is caused by mutations in genes (BRI1 or
CBB2) thought to encode proteins with roles in brassinosteroid
perception and/or signal transduction. Photographs of mutants are
enlarged relative to wild-type for easier viewing of the phenotype. The
photograph in the upper right (boxed in red) shows cpd and wild-type
plants of the same age, on the same scale for size comparison. The
det2, bri1, cbb2 and cbb3 mutants show a similar relative size
relationship to wild-type plants as the cpd mutant.
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testosterone to dihydrotestosterone by the mammalian
5a-reductase. This suggests that DET2 catalyzes the
conversion of campesterol to campestanol.
Direct proof that det2 is a brassinosteroid-deficient mutant
came from feeding experiments [10]. Brassinolide rescued
the det2 mutant phenotype to wild-type in a dose-depen-
dent manner both in the light and the dark. In contrast,
neither gibberellins nor auxin rescued the mutant pheno-
type. The observations that DET2 is required for brassi-
nosteroid biosynthesis, and that loss-of-function mutations
in DET2 lead to manifold alterations in developmental
pathways, provide convincing genetic evidence that
brassinosteroids are essential for normal plant growth.
Besides contributing to cell elongation, a well-known
brassinosteroid effect, it appears that brassinosteroid
levels play a role in other etiolated developmental
responses, as well as leaf development, apical dominance,
flowering time, fertility and senescence in the light.
Further genetic evidence that brassinosteroids play an
essential role in plant development comes from recent
work at the Max Planck Institute. By screening an Ara-
bidopsis mutant collection for plants defective in hypocotyl
elongation in the dark, Szekeres et al. [11] identified a
recessive mutation called cpd — for constitutive photomor-
phogenesis and dwarfism — with a phenotype similar to
det2 (though cpd and det2 are not allelic). In the dark, the
cpd mutant displayed the typical de-etiolated response,
while in the light it was an extreme dwarf (20–30-fold
smaller than wild type). The latter, dwarf phenotype
included: dark green, rounded, downward-curling leaves,
chloroplast development in roots, altered stomatal density,
thick transverse files of cellulose microfibrils in hypocotyl
epidermal cells, unequal division of the cambium produc-
ing extra phloem cells at the expense of xylem, and male
sterility due to the inability of pollen to elongate. 
The CPD gene was cloned and found to encode a protein
with 50–90 % sequence identity to conserved domains of
microsomal cytochrome P450 monooxygenases [11]. Fur-
thermore, the sequence shows some similarity to the spe-
cific domains of steroid hydroxylases, including rat
testosterone-16a-hydroxylase (24 % identity) and human
progesterone-21a-hydroxylase (19 % identity). Therefore,
it appears that the CPD gene encodes another enzyme in
brassinosteroid biosynthesis, this time involving a hydrox-
ylation step. When the cpd mutant was grown in the
presence of C-23 hydroxylated brassinosteroid precursors
(Fig. 1) — including teasterone, 3-dehydroteasterone,
typhasterol and castasterone — it was completely rescued
to a wild-type phenotype in light or darkness. However,
cathasterone and its precursors, which lack a hydroxyl at
C-23, failed to rescue the cpd mutant, suggesting that the
CPD protein acts in the hydroxylation of cathasterone to
teasterone during brassinosteroid biosynthesis.
The overlapping phenotypes of det2 and cpd mutants
provide confirmation of the role of brassinosteroids in the
aspects of development outlined above. The altered
microfibril orientation and xylem development in the cpd
mutant confirms previous physiological studies that impli-
cated brassinosteroids in these processes. An allele of cpd,
called cabbage3 (cbb3), has been independently isolated
[12]. A careful study of cbb3 responses to phytohormones
and their antagonists showed that auxins, auxin antago-
nists, gibberellins, ethylene-releasing compounds, ethyl-
ene inhibitors, cytokinins and jasmonic acid could not
rescue the cbb3 phenotype. Moreover, only active brassi-
nosteroids, and not any other structurally related sterol,
could rescue the cbb3 mutant phenotype to wild type [12]. 
A brassinosteroid-insensitive Arabidopsis mutant, named
bri1 (brassinosteroid-insensitive), has also been identified
[13,14]. This mutant has the same severely dwarfed pheno-
type, altered leaf morphology, reduced apical dominance
and male sterility seen in the cpd and det2 mutants. The
phenotype is caused by a single recessive allele with
pleiotropic effects that profoundly influences growth and
development. The hormone insensitivity is specific to
brassinosteroids and the mutant phenotype is not rescued
by brassinosteroid treatment. A second brassinosteroid-
insensitive mutant, cbb2, has recently been isolated that has
a very similar phenotype to bri1 [12]. Expression of brassi-
nosteroid-regulated genes is absent in both brassinosteroid-
insensitive and brassinosteroid-deficient mutants [12]. It is
not surprising that both brassinosteroid-insensitive (bri1,
cbb2) and brassinosteroid-deficient (det2, cpd) mutants show
a similar dwarfed growth habit, as brassinosteroids have
long been known to promote stem elongation. In both
cases, it is likely that the lack of brassinosteroid action,
either through reduced synthesis or reduced perception,
causes a lack of cell elongation, perhaps through reduced
expression of genes encoding the molecular components of
the cell-elongation machinery. 
The availability of at least two molecular markers for
brassinosteroid biosynthesis — det2 and cpd — will allow
elegant studies of the temporal and spatial regulation of
brassinosteroid levels in response to developmental and
environmental signals. For example, the role of DET2 as a
negative regulator of de-etiolation must be expanded to a
positive role in cell elongation, given its function as a
brassinosteroid biosynthetic enzyme. Molecular probes for
DET2 and CPD will allow precise studies of the role of
light on brassinosteroid levels. Preliminary results on the
effect of light, sugar and cytokinins on CPD expression
have been reported [11]. Attempts are underway in two
laboratories to clone the BRI1 and CBB2 loci. The dra-
matic and pleiotropic effects of these mutations suggest
that BRI1 and CBB2 lie very early in the signal percep-
tion/transduction pathway. Therefore, cloning and charac-
terization of BRI1 and CBB2 should lead to a major
advance in our understanding of brassinosteroid action
and help clarify whether plants and animals share similar
mechanism of steroid-regulated gene expression.
The application of molecular genetics has brought brassi-
nosteroids from the shadows to the full spotlight of plant
hormone research. The availability of mutants and mole-
cular probes, along with increased interest by several
molecular laboratories, means that our understanding of
these neglected regulators of plant growth and develop-
ment should rapidly increase in the next few years.
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